Le Lézard
Classified in: Covid-19 virus
Subjects: CALENDAR OF EVENTS, ANNUAL MEETINGS

FAIRFAX ANNOUNCES ANNUAL MEETING WEBCAST DETAILS


TORONTO, April 07, 2020 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) has formerly announced that, due to the COVID-19 pandemic, shareholders will not be able to attend in person at its annual meeting commencing 9:30 a.m. Eastern Time on Thursday, April 16, 2020, but that there will be a webcast of the formal annual meeting and a presentation by Prem Watsa, Fairfax's Chair and CEO, followed by a Q&A session.  Following are instructions on how to access this webcast and to submit questions for the Q&A.  

Shareholders are encouraged to access the audio webcast, which may be found at https://www.gowebcasting.com/10598 beginning at 9:15 a.m. Eastern Time on Thursday, April 16, 2020. Alternatively, shareholders may also access the meeting by telephone beginning at such time at (888) 390-0867 (Canada and U.S.) or 1 (212) 547-0141 (International) with the passcode "2675260".

Questions can be submitted by e-mailing them to [email protected]. The questions will be received by Fairfax's moderators, Jeff Fenwick, Managing Director, Co-Head of Institutional Equity Research, Cormark Securities Inc. and Jeffrey Stacey, Chairman & CEO, Stacey Muirhead Capital Management Ltd., who will facilitate the Q&A session. 

Shareholders are encouraged to vote by proxy in advance of the meeting by one of the methods described in the management proxy circular.  Instructions on voting via proxy can be found in the management proxy circular and the proxy form sent to all shareholders.

Fairfax is a holding company which, through its subsidiaries, is engaged in property and casualty insurance and reinsurance and the associated investment management.

For further information contact:John Varnell, Vice President, Corporate Development at (416) 367-4941


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

28 mar 2024
Boat Rocker Media Inc. ("Boat Rocker" or the "Company") , an independent, integrated global entertainment company, today reported its financial results for the three months ended December 31, 2023 ("fourth quarter" or "Q4") and for the year ended...



News published on and distributed by: